Benjamin Burggraaf

6PUBLICATIONS
8CO-AUTHORS
Respiratory diseasesMetabolic medicineMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 24, 2026
LAP-defined hepatic steatosis and cardiometabolic risk in rheumatoid arthritis: a post-hoc analysis of the FRANCIS randomized trial.

|Feb 17, 2025
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk factors in rheumatoid arthritis.

A N Saidi, W B Theel, B Burggraaf

|Mar 21, 2022
Effects of dapagliflozin on postprandial lipid metabolism in type 2 diabetes mellitus.

Benjamin Burggraaf, Nadine M C Pouw, Salvador Fernández Arroyo

|Jan 09, 2020
A placebo-controlled proof-of-concept study of alirocumab on postprandial lipids and vascular elasticity in insulin-treated patients with type 2 diabetes mellitus.

Benjamin Burggraaf, Nadine M C Pouw, Salvador Fernández Arroyo

|Jan 06, 2019
Effect of a treat-to-target intervention of cardiovascular risk factors on subclinical and clinical atherosclerosis in rheumatoid arthritis: a randomised clinical trial.

Benjamin Burggraaf, Deborah F van Breukelen-van der Stoep, Marijke A de Vries

|Dec 13, 2017
Evidence for increased chylomicron remnants in rheumatoid arthritis.

Benjamin Burggraaf, Deborah F van Breukelen-van der Stoep, Jendé van Zeben

Pageof 1

Frequent Collaborators

2 joint publications

A N Saidi

2 joint publications

A J van der Lelij

2 joint publications

E van der Zwan-van Beek

1 joint publications

W B Theel